Pediatric Hematologic and Neoplastic Disorders

This sickling leads to two primary pathological processes: hemolysis (destruction of RBCs) and vaso-occlusion (blockage of blood vessels). Key clinical complications include:

• Vaso-occlusive crises: Ischemic pain caused by blocked blood flow.
• Sequestration crises: Rapid pooling of blood in the spleen or liver.
• Aplastic crises: A sudden drop in RBC production.

Pharmacological management often includes hydroxyurea, which is used to increase the levels of HbF (fetal hemoglobin) to reduce sickling.

Hemolytic Disease of the Fetus and Newborn (HDFN)

HDFN occurs when maternal IgG antibodies cross the placenta and attack fetal RBCs. While ABO incompatibility can occur, Rh HDFN (an Rh-negative mother with an Rh-positive fetus) is typically more severe. Severe cases can lead to life-threatening conditions such as kernicterus (brain damage from high bilirubin) or hydrops fetalis. This can be prevented using RhoGAM.

Coagulation and Platelet Disorders

Hemostasis is the process of stopping bleeding and is divided into primary hemostasis (platelet plug formation) and secondary hemostasis (the coagulation cascade).

Hemophilia

Hemophilia represents a failure of secondary hemostasis due to inherited deficiencies in clotting factors. Unlike platelet disorders that cause superficial bruising, hemophilia typically causes deep tissue bleeding and hemarthrosis (bleeding into joints).

• Hemophilia A: A deficiency in Factor VIII.
• Hemophilia B: A deficiency in Factor IX.

Both types result in an increased PTT (activated partial thromboplastin time) but a normal PT (prothrombin time).

Immune Thrombocytopenic Purpura (ITP)

ITP is an autoimmune disorder where antiplatelet antibodies cause the spleen to destroy platelets. This results in isolated thrombocytopenia, which manifests as "platelet-style" bleeding: petechiae, purpura, and mucosal bleeding (e.g., epistaxis or gum bleeding).

![A comparison diagram showing the difference between primary hemostasis (platelet plug formation) and secondary hemostasis (the coagulation cascade leading to fibrin stabilization).

Leukemia

Leukemia is a cancer of the blood-forming tissues. Acute Lymphoblastic Leukemia (ALL) is the most common pediatric type, accounting for approximately 75% of cases. Symptoms often arise from bone marrow failure, such as anemia (low RBCs) or thrombocytopenia (low platelets).

A critical diagnostic clue is the presence of blasts (immature cells) in the peripheral circulation. While a high White Blood Cell (WBC) count usually suggests immunity, in leukemia, the WBC count may be high while the actual functional neutrophil count is low, leaving the patient highly susceptible to infection.

Lymphoma

Lymphoma involves the malignant growth of lymphoid tissue.

• Non-Hodgkin Lymphoma (NHL): Includes subtypes such as Burkitt lymphoma, which is frequently associated with the Epstein-Barr Virus (EBV).
• Hodgkin Lymphoma (HL): This is specifically distinguished by the presence of Reed-Sternberg cells and typically spreads contiguously through the lymph nodes.

![A flowchart showing the regulation of hematopoiesis, illustrating how cytokines like EPO stimulate the production of erythrocytes in the bone marrow. If the case describes deep tissue bleeding or hemarthrosis, think coagulation factor problem (Secondary Hemostasis).